CYP2E1 and lung cancer: The novel developed CYP2E1 inhibitor Q11, 1‐(4‐methyl‐5‐thialzolyl) ethenone, is effective on lung cancer in mice via regulation of the macrophage polarization in the tumor inflammatory microenvironment.